We are live on ! Find out more
NIP

Nicholas Investment Partners Portfolio holdings

AUM $1.39B
1-Year Est. Return 97.11%
This Fund
S&P 500
This Quarter Est. Return
+6.34%
1 Year Est. Return
+97.11%
3 Year Est. Return
+361.61%
5 Year Est. Return
+496.81%
10 Year Est. Return
+3,647.83%
AUM
$1.32B
AUM Growth
+$174M
Cap. Flow
+$74.4M
Cap. Flow %
5.65%
Top 10 Hldgs %
23.43%
Holding
224
New
43
Increased
51
Reduced
51
Closed
37

Top Buys

Rank Stock Value
1
MDGL icon
Madrigal Pharmaceuticals
MDGL
+$31.9M
2
UTHR icon
United Therapeutics
UTHR
+$29.5M
3
VRNA
Verona Pharma
VRNA
+$20.3M
4
ARGX icon
argenx
ARGX
+$19.4M
5
DAWN
Day One Biopharmaceuticals
DAWN
+$16M

Top Sells

Rank Stock Value
1
ITCI
Intra-Cellular Therapies Inc.
ITCI
+$21.9M
2
NARI
Inari Medical, Inc. Common Stock
NARI
+$16.5M
3
RGEN icon
Repligen
RGEN
+$14.8M
4
EXE
Expand Energy Corp
EXE
+$14.3M
5
BILL icon
BILL Holdings
BILL
+$13.8M

Sector Composition

Rank Sector Weight
1 Healthcare 52.51%
2 Technology 11.88%
3 Industrials 9.25%
4 Consumer Discretionary 7.08%
5 Energy 4.77%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
IRM icon
176
Iron Mountain
IRM
$36.1B
– –
-22,696
Closed -$1.13M
IWP icon
177
iShares Russell Mid-Cap Growth ETF
IWP
$20.7B
– –
-11,979
Closed -$1M
JOBY icon
178
Joby Aviation
JOBY
$8.55B
– –
-162,009
Closed -$543K
LNG icon
179
Cheniere Energy
LNG
$52.9B
– –
-2,704
Closed -$405K
LXU icon
180
LSB Industries
LXU
$693M
– –
-129,673
Closed -$1.72M
MRVL icon
181
Marvell Technology
MRVL
$196B
– –
-15,793
Closed -$585K
NDSN icon
182
Nordson
NDSN
$17.3B
– –
-2,152
Closed -$512K
PIII icon
183
P3 Health Partners
PIII
$38.5M
– –
-29,246
Closed -$2.69M
RBC icon
184
RBC Bearings
RBC
$18B
– –
-7,968
Closed -$1.67M
RGEN icon
185
Repligen
RGEN
$9.25B
– –
-87,487
Closed -$14.8M
THS
186
DELISTED
Treehouse Foods
THS
– –
-139,500
Closed -$6.89M
VEEV icon
187
Veeva Systems
VEEV
$37.4B
– –
-80,891
Closed -$13.1M
WMB icon
188
Williams Companies
WMB
$86.1B
– –
-189,000
Closed -$6.22M
WRB icon
189
W.R. Berkley
WRB
$26.6B
– –
-27,731
Closed -$1.34M
ITCI
190
DELISTED
Intra-Cellular Therapies Inc.
ITCI
– –
-413,507
Closed -$21.9M
EDR
191
DELISTED
Endeavor Group Holdings, Inc.
EDR
– –
-21,023
Closed -$474K
CUTR
192
DELISTED
Cutera, Inc.
CUTR
– –
-307,142
Closed -$13.6M
NARI
193
DELISTED
Inari Medical, Inc. Common Stock
NARI
– –
-260,123
Closed -$16.5M
EVA
194
DELISTED
Enviva Inc.
EVA
– –
-63,481
Closed -$3.36M
ISEE
195
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
– –
-209,976
Closed -$4.5M
HZNP
196
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
– –
-103,724
Closed -$11.8M
4 5 6 7
8

Similar funds

FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
1CP
1607 Capital Partners Richmond, Virginia $1.39B AUM 8.35% 1-Year Est. Return
OCM
Opti Capital Management New York $1.39B AUM 0% 1-Year Est. Return
OCAM
Owl Creek Asset Management New York $1.38B AUM 59.67% 1-Year Est. Return
TA
Trivest Advisors Hong Kong $1.39B AUM 273.03% 1-Year Est. Return
AU
Algebris (UK) London, United Kingdom $1.38B AUM 3.87% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return
BCP
Blue Chip Partners Farmington Hills, Michigan $1.39B AUM 22.32% 1-Year Est. Return

Nicholas Investment Partners's Q1 2023 Portfolio in Review

As of Q1 2023, Nicholas Investment Partners held 224 positions worth $1.32B, up 15% from $1.14B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Nicholas Investment Partners deployed $74.4M of net new capital in Q1 2023, opening 43 new positions and adding to 51 existing holdings. Its largest new stake was Madrigal Pharmaceuticals: 117,047 shares worth $28.4M.

By sector, the portfolio is most concentrated in Healthcare at 53% of assets, up from 44% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was Expand Energy Corp, an estimated $14.3M trimmed.

  • Nicholas Investment Partners's largest Q1 2023 buy was Madrigal Pharmaceuticals: 117,047 shares worth $28.4M.
  • Nicholas Investment Partners added most to argenx in Q1 2023, an estimated $19.4M increase.
  • Nicholas Investment Partners's biggest Q1 2023 reduction was Expand Energy Corp, cutting an estimated $14.3M.
  • Nicholas Investment Partners fully exited Intra-Cellular Therapies Inc. in Q1 2023, selling an estimated $21.9M.
  • Nicholas Investment Partners's ten largest holdings make up 23% of its $1.32B portfolio in Q1 2023.
  • Nicholas Investment Partners opened 43 new positions and closed 37 in Q1 2023.
  • Nicholas Investment Partners's portfolio value rose 15% quarter-over-quarter to $1.32B.

Based on Nicholas Investment Partners's 13F filing for Q1 2023, filed 12 May 2023.